Adherence to typical antipsychotics

There has been a recent transition from typical to atypical antipsychotics in the management of schizophrenia. This has been attributed to the acute side effects experienced by patients on typical antipsychotics that lead to non-adherence. However, the treatment cost with typical antipsychotics is cheaper (preferred in low-income settings) and there is no difference in the effectiveness, efficacy, discontinuation rate, side effects symptom burden with atypical antipsychotics. This study aims to determine the prevalence of non-adherence and the associated factors to typical antipsychotics among patients with schizophrenia attending a psychiatric outpatient clinic at rural tertiary facility in Uganda.